SNTI (STOCKS)
Senti Biosciences, Inc. Common Stock
$0.820000
-0.045900 (-5.30%)
Prev close: $0.865900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Timothy K. Lu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $21.30M
- Employees
- 48
- P/E (TTM)
- -0.24
- P/B (TTM)
- 2.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $18.73M |
| Operating Expenses | $66.31M |
| Research and Development | $37.60M |
| Other Operating Expenses | $28.71M |
| Operating Income/Loss | -$66.31M |
| Income/Loss From Continuing Operations After Tax | -$47.58M |
| Income/Loss From Continuing Operations Before Tax | -$47.58M |
| Net Income/Loss | -$47.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$47.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $2.52M |
| Preferred Stock Dividends And Other Adjustments | $2.52M |
| Basic Earnings Per Share | -$2.87 |
| Diluted Earnings Per Share | -$2.87 |
| Basic Average Shares | 20,856,188 |
| Diluted Average Shares | 20,856,188 |
| Assets | $52.69M |
| Current Assets | $18.16M |
| Prepaid Expenses | $1.57M |
| Other Current Assets | $16.59M |
| Noncurrent Assets | $34.53M |
| Fixed Assets | $18.69M |
| Other Non-current Assets | $15.84M |
| Liabilities | $44.56M |
| Current Liabilities | $12.03M |
| Accounts Payable | $1.77M |
| Wages | $2.12M |
| Other Current Liabilities | $8.14M |
| Noncurrent Liabilities | $32.54M |
| Equity | $8.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.12M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $52.69M |
| Net Cash Flow From Operating Activities | -$50.07M |
| Net Cash Flow From Operating Activities, Continuing | -$50.07M |
| Net Cash Flow From Investing Activities | -$195.00K |
| Net Cash Flow From Investing Activities, Continuing | -$195.00K |
| Net Cash Flow From Financing Activities | $52.01M |
| Net Cash Flow From Financing Activities, Continuing | $52.01M |
| Net Cash Flow | $1.74M |
| Net Cash Flow, Continuing | $1.74M |
| Comprehensive Income/Loss | -$47.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.58M |
| Other Comprehensive Income/Loss | -$47.58M |